Medical breakthroughs bring hope to people with brain degeneration

Ionis-HTTRx produced in Switzerland can reduce the protein that causes Huntington.

For the first time, scientists can reduce the amount of toxic proteins that lead to Huntington's disease in patients by injecting Ionis-HTTRx into the spine.

According to ABC, Ionis-HTTRx is produced by a Swiss pharmaceutical company. Tested on 46 patients in the UK, Germany, and Canada, the results showed that drugs that help the body lower the amount of huntingtin protein cause safety.

Ionis-HTTRx helps the body lower the amount of huntingtin protein to ensure safety.(Photo: huntingtonsdiseasenews.com).

"This result is groundbreaking for Huntington patients as well as their families , " said the head of the study, Ms Sarah Tabrizi, Director of Huntington Disease Center from University of London (UK). "The current problem is to quickly conduct large-scale trials to see if the drug helps reduce the disease process."

Huntington's disease is an inherited, degenerative brain disease. It makes damaged brain cells lead to loss of movement control, changes in actions and emotions, and misconceptions. Huntington's disease usually occurs in the age of 30-50 and gradually worsens with time.

There is currently no cure for Huntington's disease. Current drugs focus only on improving symptoms.

With initial success from the Ionis-HTTRx experiment, Professor Bryce Vissel, Director of the Center for Neuroscience and Renewable Medicine from Sydney University of Technology (Australia) believes that the new era has been opened."The work is the beginning of treatment for brain or spinal diseases caused by genetic mutations. There is still a lot to do, but the results are extraordinary," he said.

However, some experts warn it is too early to confirm the effectiveness of Ionis-HTTRx.

"The question is whether the drug will make a significant difference to patients. We need to wait for larger trials , " said Roger Barker from Cambridge University (UK), who participated in the work. know.